Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of PT010, PT003, and PT009 vs Symbicort in Japanese COPD Patients
NCT03262012Phase 3Completed
- Sponsor
- Pearl Therapeutics
- Start
- Aug 2016
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Breztri Aerosphere in chronic obstructive pulmonary disease (COPD), sponsored by Pearl Therapeutics. Started Aug 2016; status: completed.
02
Drugs
Breztri Aerosphere
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03262012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03262012.